English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The aim of our study was to explore whether there is an association of serum sFas (cell death apoptosis receptor) concentrations during the first week of sepsis with sepsis severity and sepsis mortality. In this observational study, septic patients were recruited. Serum sFas concentrations were determined on days 1, 4, and 8 of sepsis diagnosis. Thirty-day mortality was the outcome variable. Surviving patients (n = 181) compared to non-survivors (n = 101) presented lower serum sFas levels on day 1 (p &lt; 0.001), day 4 (p &lt; 0.001) and day 8 (p &lt; 0.001), and lower SOFA on day 1 (p &lt; 0.001), day 4 (p &lt; 0.001) and day 8 (p &lt; 0.001). Logistic regression analyses showed associations between 30-day mortality and serum sFas levels controlling for SOFA on day 1 (OR = 1.005; 95% CI = 1.003–1.007; p &lt; 0.001), day 4 (OR = 1.044; 95% CI = 1.029–1.060; p &lt; 0.001) and day 8 (OR = 1.012; 95% CI = 1.002–1.022; p = 0.02). The association of serum sFas concentrations during the first week of sepsis with sepsis severity and sepsis mortality were our new findings.

Serum Fas levels during first week of sepsis are associated with severity and mortality